Cleared Traditional

K881749 - STRAIGHT-LINE FINISH FOR IMPLANTABLE PU...

K881749 is the FDA 510(k) clearance for STRAIGHT-LINE FINISH FOR IMPLANTABLE PU... by Medtronic Vascular. It is a Class 2 Neurology device (product code GXY) cleared through the Traditional 510(k) pathway after a 84-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1988
Decision
84d
Days
Class 2
Risk

K881749 is an FDA 510(k) clearance for the STRAIGHT-LINE FINISH FOR IMPLANTABLE PULSE GENERA.. Classified as Electrode, Cutaneous (product code GXY), Class II - Special Controls.

Submitted by Medtronic Vascular (Minneapolis, US). The FDA issued a Cleared decision on July 18, 1988 after a review of 84 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1320 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Medtronic Vascular devices

Submission Details

510(k) Number K881749 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 25, 1988
Decision Date July 18, 1988
Days to Decision 84 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
64d faster than avg
Panel avg: 148d · This submission: 84d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code GXY Electrode, Cutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1320
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GXY Electrode, Cutaneous

All 141
Devices cleared under the same product code (GXY) and FDA review panel - the closest regulatory comparables to K881749.
MULTIDAY, MODELS 8300 AND 8310
K882888 · Medical Devices, Inc. · Sep 1988
PROGEL (TM) DUAL ELECTRODE PAD, MODEL 8535
K882886 · Medical Devices, Inc. · Sep 1988
PROGEL(TM), MODELS 8630 AND 8635
K882887 · Medical Devices, Inc. · Sep 1988
MEDTRONIC SNAP EASE MODEL 7795 CUTANEOUS ELECTRODE
K875284 · Medtronic Vascular · Jan 1988
TENZCARE(TM) SNAP ELECTRODE 6867
K864973 · 3M Company · Jan 1987
TENZCARE SNAP ELECTRODE, NO. 6865
K863307 · 3M Company · Sep 1986